文献速递主动脉疾病内脏/肾动脉与血管畸形

三维技术规划医师改良开窗支架治疗复杂主动脉病变的系统综述与荟萃分析

Physician-Modified Fenestrated Stent-Grafts Planned Using Three-Dimensional Techniques for Complex Aortic Pathology: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-06-26

该系统综述与荟萃分析纳入5项研究共172例患者,评估三维技术规划的医师改良开窗支架(PMSG)治疗复杂主动脉病变的效果与安全性。加权平均随访14.9个月,技术成功率92.9%,靶血管通畅率96.9%,早期死亡率5.5%,内漏发生率13.3%,再干预率6.6%。结论认为该技术成功率高且靶血管通畅良好,但内漏和再干预率存在异质性,需前瞻性研究确认长期结局。

要点

  • 三维规划PMSG治疗复杂主动脉病变技术成功率达92.9%,靶血管通畅率96.9%。
  • 早期死亡率为5.5%,内漏发生率为13.3%,再干预率为6.6%。
  • 内漏和再干预率的异质性可能反映解剖复杂度和患者选择差异。

核心结论

  • 三维技术规划的PMSG手术在复杂主动脉病变患者中与高技术成功率和靶血管通畅率相关。
  • 内漏和再干预率的变异性可能反映研究间解剖复杂度和患者选择的差异,需进一步前瞻性研究确认长期结局。

研究设计与样本

  • 系统检索PubMed/MEDLINE和Embase数据库,纳入描述使用三维工具规划的医师改良开窗支架的研究。
  • 采用随机效应模型和限制性最大似然估计进行荟萃分析,比例分析使用logit转换。
  • 共纳入5项研究,涉及172例患者,估计加权平均随访时间为14.9个月。

主要发现

  • 总体技术成功率为92.9%(95%CI:84.5-96.9%),异质性低至中等。
  • 靶血管通畅率为96.9%(95%CI:93.6-98.5%)。
  • 早期死亡率为5.5%(95%CI:2.1-13.3%)。
  • 内漏发生率为13.3%(95%CI:5.8-27.4%),研究间存在显著异质性。
  • 再干预率为6.6%(95%CI:2.3-17.5%)。

临床怎么用

  • 对于不适合标准EVAR且定制开窗支架不可及时,三维规划PMSG可作为复杂主动脉病变的实用替代方案。
  • 需关注术后内漏和再干预风险,根据解剖复杂度和患者选择进行个体化评估。

局限性

  • 仅纳入5项研究共172例患者,样本量有限。
  • 加权平均随访时间仅14.9个月,缺乏长期结局数据。
  • 内漏发生率存在显著异质性,可能影响合并结果的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complex aortic pathology involving the visceral arteries remains a significant therapeutic challenge. Open repair is associated with considerable perioperative risk, particularly in patients with multiple comorbidities, while standard endovascular aneurysm repair (EVAR) is often not feasible because of inadequate proximal sealing zones. Fenestrated and branched endovascular repair (F/BEVAR) represents an established treatment strategy; however, the use of custom-made devices is limited by manufacturing time and availability. Physician-modified stent grafts (PMSGs) have therefore emerged as a pragmatic alternative. Three-dimensional planning techniques have been increasingly used to facilitate accurate graft modification. The aim of this systematic review and meta-analysis was to evaluate the effectiveness and safety of PMSG procedures planned with three-dimensional techniques. Technical success, target vessel patency, early mortality, endoleak occurrence, and reintervention rates were analyzed. METHODS: A systematic search was conducted in the PubMed/MEDLINE and Embase databases. Studies describing the use of physician-modified fenestrated stent grafts planned with three-dimensional tools were included. Meta-analyses were performed using a random-effects model with restricted maximum likelihood estimation. A logit transformation was used for the analysis of proportions. RESULTS: The analysis included five studies involving 172 patients. The estimated weighted mean follow-up duration was 14.9 months. The overall technical success rate was 92.9% (95% confidence interval [CI]: 84.5-96.9%), with low-to-moderate heterogeneity. Target vessel patency was 96.9% (95% CI: 93.6-98.5%). Early mortality was 5.5% (95% CI: 2.1-13.3%). The incidence of endoleaks was 13.3% (95% CI: 5.8-27.4%), with significant heterogeneity among studies. Reinterventions were reported in 6.6% of patients (95% CI: 2.3-17.5%). CONCLUSION: The results indicate that PMSG procedures planned with three-dimensional techniques are associated with a high rate of technical success and preserved patency of target vessels in patients with complex aortic pathology. The observed variability in endoleak and reintervention rates likely reflects differences in anatomical complexity and patient selection among studies. Further prospective studies are needed to confirm long-term outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Skórka P, Miler K, Ziętara M, et al. Physician-Modified Fenestrated Stent-Grafts Planned Using Three-Dimensional Techniques for Complex Aortic Pathology: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2026. PMID: 42362017. doi:10.1016/j.avsg.2026.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。